Literature DB >> 33391260

Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice via a TGF-β-Dependent Mechanism.

David A Horwitz1,2, Aijing Liu3, Sean Bickerton4, Giuseppe Castaldo5, Giuseppe Matarese5,6, Tarek M Fahmy4,7, Antonio La Cava3.   

Abstract

We recently reported that the treatment with nanoparticles (NPs) loaded with tolerogenic cytokines suppressed the manifestations of lupus-like disease induced by the transfer of donor CD4+ T cells from DBA/2 mice into (C57BL/6 × DBA/2)F1 (BDF1) mice. Although the protective effects were ascribed to the induction of adaptive CD4+ and CD8+ T regulatory cells, the results suggested that another population of immune cells could be involved. Here we report that NK cells critically contribute to the protection from lupus-like disease conferred by NPs to BDF1 mice, and that this effect is TGF-β-dependent.
Copyright © 2020 Horwitz, Liu, Bickerton, Castaldo, Matarese, Fahmy and La Cava.

Entities:  

Keywords:  NK cells; autoimmunity; cytokines; immune regulation; immunotherapy; nanoparticles; systemic lupus erythematosus

Mesh:

Substances:

Year:  2020        PMID: 33391260      PMCID: PMC7772200          DOI: 10.3389/fimmu.2020.583338

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  28 in total

Review 1.  Natural killer cells in human health and disease.

Authors:  Jordan S Orange; Zuhair K Ballas
Journal:  Clin Immunol       Date:  2005-12-05       Impact factor: 3.969

2.  NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo.

Authors:  Hideto Nishikado; Kaori Mukai; Yohei Kawano; Yoshiyuki Minegishi; Hajime Karasuyama
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 3.  Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.

Authors:  Christina G Katsiari; George C Tsokos
Journal:  Autoimmun Rev       Date:  2005-09-26       Impact factor: 9.754

4.  Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.

Authors:  J D Gray; M Hirokawa; K Ohtsuka; D A Horwitz
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

Review 5.  The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity.

Authors:  D A Horwitz; J D Gray; K Ohtsuka; M Hirokawa; T Takahashi
Journal:  Immunol Today       Date:  1997-11

6.  Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human antimouse responses.

Authors:  D A Hafler; H L Weiner
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 7.  Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.

Authors:  David A Horwitz; Tarek M Fahmy; Ciriaco A Piccirillo; Antonio La Cava
Journal:  Trends Immunol       Date:  2019-10-07       Impact factor: 16.687

8.  Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.

Authors:  Mark R Rigby; Kristina M Harris; Ashley Pinckney; Linda A DiMeglio; Marc S Rendell; Eric I Felner; Jean M Dostou; Stephen E Gitelman; Kurt J Griffin; Eva Tsalikian; Peter A Gottlieb; Carla J Greenbaum; Nicole A Sherry; Wayne V Moore; Roshanak Monzavi; Steven M Willi; Philip Raskin; Lynette Keyes-Elstein; S Alice Long; Sai Kanaparthi; Noha Lim; Deborah Phippard; Carol L Soppe; Margret L Fitzgibbon; James McNamara; Gerald T Nepom; Mario R Ehlers
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

9.  Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.

Authors:  Jing He; Xia Zhang; Yunbo Wei; Xiaolin Sun; Yaping Chen; Jun Deng; Yuebo Jin; Yuzhou Gan; Xin Hu; Rulin Jia; Chuanhui Xu; Zhaohua Hou; Yew Ann Leong; Lei Zhu; Jinhong Feng; Yuan An; Yuan Jia; Chun Li; Xu Liu; Hua Ye; Limin Ren; Ru Li; Haihong Yao; Yuhui Li; Shi Chen; Xuewu Zhang; Yin Su; Jianping Guo; Nan Shen; Eric F Morand; Di Yu; Zhanguo Li
Journal:  Nat Med       Date:  2016-08-08       Impact factor: 53.440

Review 10.  Roles of CD48 in regulating immunity and tolerance.

Authors:  Shannon L McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  Clin Immunol       Date:  2016-01-18       Impact factor: 3.969

View more
  1 in total

Review 1.  Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases.

Authors:  David A Horwitz; Sean Bickerton; Antonio La Cava
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.